Yeast food supplement helps immune cells fight cancer more effectively
Researchers from Trinity College Dublin (TCD) and University College Dublin (UCD) have shown for the first time that…
GLP-1 Weight Loss Drug Use Triples, as Obesity Declines
A growing number of Americans are turning to GLP-1 drugs to slim down. A new Gallup survey…
‘Mitch’ protein that could change the future of weight loss and fat burning
Could a single protein hold the key to a new generation of obesity treatments? Mitch, please! That’s what…
Men’s Testosterone Levels Have Fallen by Half in 50 Years and Scientists Are Worried
Image credits: Julien Tromeur. Something keeps happening to men’s hormones. Across nearly 50 years and five countries, testosterone…
WHO: Global Cancer Cases May Surge Almost 70% by 2050
The World Health Organization is warning that the global cancer burden is on track to soar, with…
Breaking up long periods of sitting is linked to lower cancer risk
Spending less time in long, uninterrupted sitting bouts and replacing some of that time with even light physical activity was…
Medicare GLP-1 Bridge program offers Wegovy, Zepbound for $50 a month
Novo Nordisk to slash Wegovy, Ozempic list prices Board certified rheumatologist Dr. Mahsa Tehrani discusses Novo Nordisk’s decision…
Secret shopper study reveals questionable telehealth GLP-1 practices
Katie covers the impact of health technology on patients, clinicians, and businesses. Her stories explore the price tag…
Weight-loss pills now on sale for £79
Pharmacies are already facing huge demand for weight-loss pills as the tablets go on sale for the first…
Scientists Say Intermittent Fasting Could Make Weight Loss Easier
Intermittent fasting may offer a more sustainable path to weight loss for people who struggle with traditional dieting,…
Cardiovascular medicines are changing the health risks of obesity
People with obesity have worse cardiovascular health than people with normal weight, especially as they get older, right?…
Strengthening the metabolic alliance: exercise as an essential partner of obesity pharmacotherapy
Competing interests J.B. has received speaking fees from Novo Nordisk and Eli Lilly for educational activities related to…